Loyal
company
About
Loyal is a biotechnology company developing medicines to extend dog lifespan.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $27M
- Industries
- Biotechnology,Pet,Veterinary
- Founded date
- Jan 1, 2019
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$27M
Loyal has raised a total of
$27M
in funding over 2 rounds. Their latest funding was raised on
Sep 23, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 23, 2021 | Series A | $27M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Loyal is funded by 1 investors.
Predictive VC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Predictive VC
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
